Hydroxyamphetamine hydrobromide

Solutions should be freshly prepared and protected from exposure to light. Application 6-Hydroxydopamine hydrobromide has been used: to induce Parkinson&#8242s disease (PD) in mouse models to study the effects of tubastatin A (TBA) on

Solutions should be freshly prepared and protected from exposure to light. Application 6-Hydroxydopamine hydrobromide has been used: to induce Parkinson&#8242s disease (PD) in mouse models to study the effects of tubastatin A (TBA) on

Solutions should be freshly prepared and protected from exposure to light. Application 6-Hydroxydopamine hydrobromide has been used: to induce Parkinson&#8242s disease (PD) in mouse models to study the effects of tubastatin A (TBA) on

Solutions should be freshly prepared and protected from exposure to light. Application 6-Hydroxydopamine hydrobromide has been used: to induce Parkinson&#8242s disease (PD) in mouse models to study the effects of tubastatin A (TBA) on

6-hydroxyhexan-2-one.

6-hydroxyhexan-2-one.

Poly-D-Lysine (PDL) and Poly-L-Lysine (PLL) are synthetic compounds that enhance cell adhesion and protein absorption by altering surface charges on the culture substrate. In addition to promoting cell adhesion, poly-lysine surface treatments

Poly-D-Lysine (PDL) and Poly-L-Lysine (PLL) are synthetic compounds that enhance cell adhesion and protein absorption by altering surface charges on the culture substrate. In addition to promoting cell adhesion, poly-lysine surface treatments

Poly-D-Lysine (PDL) and Poly-L-Lysine (PLL) are synthetic compounds that enhance cell adhesion and protein absorption by altering surface charges on the culture substrate. In addition to promoting cell adhesion, poly-lysine surface treatments

Poly-D-Lysine (PDL) and Poly-L-Lysine (PLL) are synthetic compounds that enhance cell adhesion and protein absorption by altering surface charges on the culture substrate. In addition to promoting cell adhesion, poly-lysine surface treatments

Other Notes Please note that Sigma-Aldrich provides this product to early discovery researchers as part of a collection of rare and unique chemicals. Sigma-Aldrich does not collect analytical data for this product.

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the